Health tech startup Doceree closes seed funding round of $1 M. Physician engagement Doceree startup will use the funding for customer acquisition and scaling up of business in both the launch markets – India and the US.
New Delhi, May 12, 2020: Doceree Inc., (www.doceree.com), the world’s first programmatic physician engagement platform, has raised $1 million in seed funding from a group of angel investors from India and the United States. The New Jersey-based Doceree successfully secured the funds despite the unprecedented corona virus crisis that is wreaking havoc on stocks worldwide, causing a meltdown in investment sentiment globally. The health-tech startup plans to utilize the funds for customer acquisition, recruiting talent, scaling up operations in India and the US and ramping up technology to further digitalize physician engagement experience.
The seed funding round was led by Kumar Gaurav, Founder & CEO of Beyond Codes in which other investors from advertising and pharmaceutical industry participated. Doceree, that connects pharma brands and digital platforms and allows products and services of the former to be marketed to physicians on the latter’s platforms, has also inducted Rahul Gupta in the management board. Mr Gupta is a serial investor in over 15 IT, ITES, Healthcare and the Real Estate sector businesses.
Founded in 2019, Doceree aims to address the problem of rising cost of healthcare by bringing efficiency and effectiveness to physician engagement by using data and creativity in healthcare marketing. Dr. Harshit Jain, Founder and CEO, Doceree, who began his career as a healthcare specialist and later turned full-time to healthcare marketing, said Doceree is playing a pivotal role in improving healthcare delivery and outcomes by building brand relationships with healthcare professionals (HCPs) and adding genuine and long-term value to them through data-driven endemic marketing.
“In the healthcare space, there is a huge data that lies underutilized which when used efficiently can drastically change the way physicians are engaged. The challenge is that despite changing dynamics and the surge of digitisation, it’s still hard for pharmaceutical brands to approach physicians on the digital medium. While pharma companies spend a huge amount to market physicians in the traditional way, they are not able to tap the vast potential of the digital medium to grow their businesses. That is the gap Doceree plugs by helping them make the most of the Digital Physician Ecosystem through its Programmatic Physician Engagement Platform,” said Dr. Harshit.
The company witnessed a massive growth since its launch in the US, being able to create an expansive network of 1 million physicians there in an incredibly short span of time. After gaining a strong foothold in the US market, Doceree launched its India operations in mid-March this year, having advanced its entry to let pharmaceutical companies gain access to physicians amid corona virus pandemic through its platform for free, in its bid to support them when their crucial workforce of medical and sales representatives are locked indoors.
“Doceree’s concept of programmatic physician engagement is distinct, disruptive and innovative. How it became a crucial tool for pharma companies to reach out to doctors during the ongoing COVID-19 crisis establishes the greater need and importance of the platform. The future of digital access to physicians is very promising and we truly believe in Doceree’s vision,” said Rahul Gupta.
The company replicated the huge response it received in the US, in India as well. A significant number of renowned pharma brands and digital platforms are already using Doceree platform in both India and the US. Doceree enables pharma companies to market to physicians using technology to automatically serve ads — reaching the right user with the right message at the right time, optimising efficiency i.e. clicks and conversions, reducing waste and ensuring effective measurement of return on investment (RoI).
